GCT Semiconductor Holding, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
GCTS$1.45+5.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Loss
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Comprehensive loss, net of taxes: | ||||
| Net loss | $(13,849) | $(7,121) | $(34,355) | $(7,407) |
| Foreign currency translation adjustment | 855 | (1,180) | (888) | 592 |
| Comprehensive loss | $(12,994) | $(8,301) | $(35,243) | $(6,815) |
| Accumulated | ||||||
|---|---|---|---|---|---|---|
| Additional · Other · Total | ||||||
| Common Stock · Paid-In · Comprehensive · Accumulated · Stockholders’ | ||||||
| Shares | Amount | Capital | Income (Loss) | Deficit | Deficit | |
| Balance as of December 31, 2024 | 47,987 | $5 | $501,195 | $1,518 | $(562,033) | $(59,315) |
| Issuance of common stock under common stock purchase agreement | 74 | — | 189 | — | — | 189 |
| Issuance of common stock upon exercise of stock options | 173 | — | 19 | — | — | 19 |
| Release of vested restricted stock units | 19 | — | — | — | — | — |
| Shares withheld related to net share settlement of restricted stock units | (6) | — | (11) | — | — | (11) |
| Stock-based compensation | — | — | 511 | — | — | 511 |
| Foreign currency translation adjustment | — | — | — | (51) | — | (51) |
| Net loss | — | — | — | — | (6,968) | (6,968) |
| Balance as of March 31, 2025 | 48,247 | 5 | 501,903 | 1,467 | (569,001) | (65,626) |
| Issuance of common stock under common stock purchase agreement | 1 | — | 1 | — | — | 1 |
| Issuance of common stock under at-market agreement | 298 | — | 471 | — | — | 471 |
| Issuance of common stock and common stock warrants in a registered direct offering | 7,006 | 1 | 9,893 | — | — | 9,894 |
| Issuance of common stock upon exercise of stock options | 14 | — | 2 | — | — | 2 |
| Release of vested restricted stock units | 218 | — | — | — | — | — |
| Stock-based compensation | — | — | 512 | — | — | 512 |
| Foreign currency translation adjustment | — | — | — | (1,692) | — | (1,692) |
| Net loss | — | — | — | — | (13,538) | (13,538) |
| Balance as of June 30, 2025 | 55,784 | 6 | 512,782 | (225) | (582,539) | (69,976) |
| Issuance of common stock under at-market agreement | 590 | — | 950 | — | — | 950 |
| Issuance of common stock upon exercise of stock options | 1 | — | — | — | — | — |
| Release of vested restricted stock units | 90 | — | — | — | — | — |
| Stock-based compensation | — | — | 1,871 | — | — | 1,871 |
| Foreign currency translation adjustment | — | — | — | 855 | — | 855 |
| Net loss | — | — | — | — | (13,849) | (13,849) |
| Balance as of September 30, 2025 | 56,465 | $6 | $515,603 | $630 | $(596,388) | $(80,149) |
| Accumulated | ||||||
|---|---|---|---|---|---|---|
| Additional · Other · Total | ||||||
| Common Stock · Paid-In · Comprehensive · Accumulated · Stockholders’ | ||||||
| Shares | Amount | Capital | Income (Loss) | Deficit | Deficit | |
| Balance as of December 31, 2023 | 24,166 | $3 | $435,752 | $(1,538) | $(549,654) | $(115,437) |
| Reverse recapitalization transaction, net of transaction costs and acquired liabilities | 21,667 | 2 | 50,031 | — | — | 50,033 |
| Stock-based compensation | — | — | 1,223 | — | — | 1,223 |
| Foreign currency translation adjustment | — | — | — | 1,064 | — | 1,064 |
| Net income | — | — | — | — | 757 | 757 |
| Balance as of March 31, 2024 | 45,833 | 5 | 487,006 | (474) | (548,897) | (62,360) |
| Issuance of common stock under common stock purchase agreement | 679 | — | 3,388 | — | — | 3,388 |
| Issuance of commitment shares in connection with common stock purchase agreement | 57 | — | — | — | — | — |
| Issuance of common stock to underwriter | 110 | — | 667 | — | — | 667 |
| Stock-based compensation | — | — | 323 | — | — | 323 |
| Foreign currency translation adjustment | — | — | — | 708 | — | 708 |
| Net loss | — | — | — | — | (1,043) | (1,043) |
| Balance as of June 30, 2024 | 46,679 | 5 | 491,384 | 234 | (549,940) | (58,317) |
| Issuance of common stock under common stock purchase agreement | 1,422 | — | 5,541 | — | — | 5,541 |
| Issuance of common stock and common stock warrants in a private placement | 742 | — | 2,240 | — | — | 2,240 |
| Issuance of common stock upon exercise of stock options | 118 | — | 13 | — | — | 13 |
| Forfeiture of unvested sponsor earnout shares | (1,350) | — | — | — | — | — |
| Stock-based compensation | — | — | 573 | — | — | 573 |
| Foreign currency translation adjustment | — | — | — | (1,180) | — | (1,180) |
| Net loss | — | — | — | — | (7,121) | (7,121) |
| Balance as of September 30, 2024 | 47,611 | $5 | $499,751 | $(946) | $(557,061) | $(58,251) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.